Enterprise Value
238.5M
Cash
37.86M
Avg Qtr Burn
-10.11M
Short % of Float
0.03%
Insider Ownership
70.30%
Institutional Own.
3.93%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
AP-PA02 Details Non-Cystic Fibrosis Bronchiectasis | Phase 2 Data readout | |
AP-SA02 Details Bacterial infection | Phase 2a Data readout | |
AP-PA02 Details Cystic fibrosis | Phase 1/2 Update |